Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3201–3250 of 18623
the Company also announced that David Jackola will serve as Interim Chief Financial Officer upon Krumm’s departure and until a successor is named.
On November 22, 2024, APi Group Corporation (the “Company”) announced that Kevin Krumm, Executive Vice President and Chief Financial Officer, has resigned and will leave the Company effective December 13, 2024 to pursue another professional opportunity.
On November 21, 2024, the Company appointed Victor Balan, who was previously serving as Director and Treasurer, to fill the vacancies created by the resignation of the Former Officer. Effective immediately, Victor Balan will assume the roles of President, Secretary, CEO, and will continue to serve as Director and Treasurer.
On November 21, 2024, Yuliia Zaporozhan, a member of the Board of Directors of the Stagewise Strategies Corp. (the “Company”) notified the Company of her intention to resign from her positions as President, Director, Secretary, and CEO of the Company, effective November 21, 2024.
On August 27, 2024, Insperity, Inc. (the “Company”) announced the retirement of Douglas S. Sharp, Executive Vice President of Finance, Chief Financial Officer and Treasurer, effective November 15, 2024.
Brian P. McKeon, Executive Vice President, Chief Financial Officer and Treasurer of IDEXX Laboratories, Inc. (the “Company” or “IDEXX”) notified the Company that he will retire from IDEXX effective June 1, 2025.
the Board appointed Andrew Emerson, currently Senior Vice President, Corporate and Companion Animal Group (“CAG”) Finance of the Company, as Executive Vice President, Chief Financial Officer and Treasurer of the Company, effective March 1, 2025.
On such date, the Company’s board of directors (the “Board”) also appointed Dave Rawden from AlixPartners LLP (“AlixPartners”), a leading global business advisory firm, as Interim Chief Financial Officer, and designated him as principal financial officer and principal accounting officer.
On November 20, 2024, Mark Donohue, the Chief Financial Officer and principal financial officer and principal accounting officer of Evolv Technologies Holdings, Inc. (the “Company”), resigned effective November 21, 2024.
As a result of this designation, Gregory A. Izenstark, the Company’s Executive Vice President and Chief Financial Officer, stepped down as the Company’s principal accounting officer but will continue to serve as the Company’s principal financial officer.
Jonathan Douyard has been appointed to be the Executive Vice President, Chief Financial Officer and Treasurer of the Company, effective on January 1, 2025
Phillip Eyler, the Company’s President and Chief Executive Officer, and Interim Chief Financial Officer, will depart from the Company effective December 31, 2024
On November 15, 2024, Douglas Beck was appointed Chief Financial Officer of the Company, effective November 22, 2024.
On November 20, 2024, John Small provided notice of his decision to resign as Chief Financial Officer of AiAdvertising, Inc. (the “Company”), effective November 22, 2024.
On November 19, 2024, the Board of Directors of J & J Snack Foods Corp. (“J & J” or the “Company”) approved, effective as of December 2, 2024 (the “Start Date”), the appointment of Shawn Munsell to the position of Senior Vice President, Chief Financial Officer to fill the position of Ken Plunk, the current Chief Financial Officer, whose retirement was announced in June 2024.
whose retirement was announced in June 2024.
On November 15, 2024, the Company’s Board of Directors appointed Mr. YUM Edward Liang Hsien (“Mr. YUM”), aged 45, to act as the President, Secretary, Treasurer, Chief Executive Officer, Chief Financial Officer and the Chairman of Board of Directors of the Company.
On November 15, 2024, Ms. CHENG Sau Heung (“Ms. CHENG”) resigned her positions as President, Chief Executive Officer, Secretary, Treasurer and the Chairman of Board of Directors of the Company.
On November 20, 2024, the Chairman and Chief Executive Officer of Flux Power Holdings, Inc. (the “Company or “Flux Power”), Ronald Dutt, notified the Company’s Board of Directors (the “Board”) that he intends to retire from his positions upon the appointment of a successor.
On November 21, 2024, the Company appointed Eric Prengel, who currently serves as Group Vice President, Finance at the Company, as Elastic’s interim Chief Financial Officer, effective as of December 14, 2024.
On November 18, 2024, Janesh Moorjani, the Company’s Chief Financial Officer and Chief Operating Officer, notified the Company of his decision to resign from his positions as Chief Financial Officer and Chief Operating Officer, in which positions he serves as the Company’s principal financial officer, principal accounting officer, and principal operating officer.
Effective November 11, 2024, the Company appointed Mr. Joseph Cleghorn as Chief Executive Officer, interim Chief Financial Officer, and Director.
Effective November 11, 2024, the Company appointed Mr. Joseph Cleghorn as Chief Executive Officer, interim Chief Financial Officer, and Director.
the Board elected Microchip’s former Chief Executive Officer and President, Steve Sanghi, to serve as interim Chief Executive Officer and President effective November 18, 2024.
Additionally, effective as of November 18, 2024, Andrew E. Tometich no longer serves as the Company’s Chief Executive Officer and President or as a member of the Board.
On November 14, 2024, the Board of Directors (the “Board”) of Quaker Chemical Corporation (the “Company”), appointed Joseph A. Berquist, age 53, the Company’s Chief Commercial Officer, to serve as Chief Executive Officer and President, effective November 18, 2024.
the Company employed a senior management team comprised of its current executive officers, Jeffrey B. Lown II, the Company’s President and Chief Executive Officer, Michael A. Hutchby, the Company’s Chief Financial Officer, and Julian B. Evans, the Company’s Chief Investment Officer.
the Company employed a senior management team comprised of its current executive officers, Jeffrey B. Lown II, the Company’s President and Chief Executive Officer, Michael A. Hutchby, the Company’s Chief Financial Officer, and Julian B. Evans, the Company’s Chief Investment Officer.
On November 18, 2024, the Nominating and Corporate Governance Committee of the Board nominated and the Board appointed Ms. Jia Yang as the CEO of the Company and the chairwoman of the Board to fill the vacancy resulting from Mr. Ziyun Liu’s resignation.
On November 16, 2024, Mr. Ziyun Liu resigned from his position as the chief executive officer (“ CEO ”) of Singularity Future Technology Ltd. (the “ Company ”) and as a director and the chairman of the board of directors of the Company (the “ Board ”).
the Company appointed Donald Owens, Chairman of the Board of Directors, as the Company’s Chief Executive Officer, President and Secretary.
the Company accepted the resignation from Paul Mueller as the Company’s Chief Executive Officer, President and Secretary.
Mr. Abrams succeeds Interim Chief Financial Officer Richard Narido, who will continue to support the Company’s financial function and other projects.
On November 18, 2024, NRx Pharmaceuticals, Inc. (the “ Company ”) issued a press release announcing the appointment of Michael Abrams as the Chief Financial Officer of the Company.
Xixuan Hei was appointed as Chairman, Chief Executive Officer, Chief Financial Officer and a Director of the Company.
Bruce Revzin as Chief Financial Officer of the Company
Scott Savitz as Chairman (but continuing as a director) and Chief Executive Officer of the Company
Ho Seok (Roberto) Kim resigned as Chief Financial Officer of the Company, which resignation was not as a result of any disagreements with the Company or its management.
On November 14, 2024, Houston American Energy Corp. (the “ Company ”) appointed Stephen Hartzell as its Acting Chief Financial Officer
Michael Secora On November 20, 2024, the Company announced that Michael Secora (“Dr. Secora”), Chief Financial Officer of the Company, will be transitioning from his role as Chief Financial Officer, effective as of November 20, 2024.
Ben Taylor On November 20, 2024, the Board appointed Ben Taylor (“Mr. Taylor”), age 47, as Chief Financial Officer of the Company and President of Recursion UK, effective as of November 20, 2024.
Ryan Greenier, the Company's Executive Vice President and Chief Financial Officer, will assume the role of Principal Accounting Officer upon Ms. Johnson's retirement.
On November 18, 2024, Virpax Pharmaceuticals, Inc. (the “Company”) appointed Mr. Usama Chaudhry as Chief Financial Officer of the Company under an Independent Contractor Agreement (the “Agreement”) with Chaudhry U Consulting Inc., a Canadian corporation represented by Mr. Chaudhry.
On November 19, 2024, Labcorp Holdings Inc. (“Labcorp”) announced that on November 15, 2024, Glenn Eisenberg notified Labcorp of his intention to retire from Labcorp effective April 30, 2025.
Julia Wang, age 54, was appointed to the position of Executive Vice President and Chief Financial Officer ("CFO").
On November 19, 2024, the Company announced that its Board of Directors (the “Board”) has concluded its search for a Chief Executive Officer and has appointed Kenneth (Ken) D. Seipel, the Company’s Interim Chief Executive Officer and a member of the Board, to serve as its permanent Chief Executive Officer, effective as of November 18, 2024.
At the Effective Time, Joseph Flanagan, a director of the Company immediately prior to the Merger, became the Chief Executive Officer of the Surviving Corporation.
Accordingly, on that date, Mr. Wright resigned from his positions as Chairman of the Board, Director and Chief Executive Officer of the Company, effective upon and subject to the Confirmation Condition.
Subject to the Confirmation Condition and in accordance with the Company’s succession plan, the Board appointed William Kimble as the non-executive Chairman of the Board and Ron Gusek as the Company’s Chief Executive Officer.
On November 12, 2024, John C. Lee, Jr. gave notice of his resignation as President and Chief Executive Officer ("CEO") of Old Dominion Electric Cooperative ("ODEC"), effective February 1, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.